Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice. FE [Internet]. 2008 Jan. 15 [cited 2025 Oct. 29];9(4):173-81. Available from: https://journals.seedstm.com/index.php/FE/article/view/235